Healthcare -
Biotechnology - NASDAQ - US
$ 5.155
-0.194 %
$ 233 M
Market Cap
-4.72
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Third Harmonic Bio, Inc.
| Net Income | -45.5 M |
| Depreciation & Amortization | 49 K |
| Capital Expenditures | -10 K |
| Stock-Based Compensation | 11.1 M |
| Change in Working Capital | -893 K |
| Others | -268 K |
| Free Cash Flow | -34.5 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (45.5) | (30.8) | (35.2) | (29.6) | (12.8) |
| Depreciation & Amortization | 49 K | 35 K | 1 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 11.1 | 9.6 | 4.8 | 0.5 | 0.2 |
| Other Operating Activities | 0.7 | 0.6 | 37 K | 10.6 | 1.7 |
| Change in Working Capital | (0.9) | 0.2 | (4.6) | 2.7 | 1.7 |
| Cash From Operations | (34.5) | (20.4) | (34.9) | (15.7) | (9.2) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 10 K | (0.2) | 36 K | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 10 K | (0.2) | 36 K | 0 | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.8 | 0.8 | (2.2) | 135.7 | 10.8 |
| Cash From Financing Activities | 50.5 | 0.8 | 196.0 | 135.7 | 10.8 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 16.0 | (19.8) | 161.0 | 120.0 | 1.6 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (34.5) | (20.6) | (35.0) | (15.7) | (9.2) |